A trial of P2Y(12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease.

BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is characterized by asthma, recurrent nasal polyposis, and respiratory reactions upon ingestion of cyclooxygenase-1 inhibitors. Increased numbers of platelet-leukocyte aggregates are present in the sinus tissue and blood of patients with AER...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Laidlaw, Tanya M., Cahill, Katherine N., Cardet, Juan Carlos, Murphy, Katherine, Cui, Jing, Dioneda, Brittney, Kothari, Parul, Raby, Benjamin A., Israel, Elliot, Boyce, Joshua
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286686/
https://ncbi.nlm.nih.gov/pubmed/29890239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2018.06.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados